The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-(2-cyclohexyl-4-(1-isopropylpiperidin-4-ylamino)-6-methoxyquinazolin-7-yl)prop-2-ynyl)pyrrolidin-2-one ID: ALA4552592
PubChem CID: 155556005
Max Phase: Preclinical
Molecular Formula: C30H41N5O2
Molecular Weight: 503.69
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1C#CCN1CCCC1=O
Standard InChI: InChI=1S/C30H41N5O2/c1-21(2)34-17-13-24(14-18-34)31-30-25-20-27(37-3)23(11-7-15-35-16-8-12-28(35)36)19-26(25)32-29(33-30)22-9-5-4-6-10-22/h19-22,24H,4-6,8-10,12-18H2,1-3H3,(H,31,32,33)
Standard InChI Key: YTZXLVDHUCDBOG-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
4.2785 -26.2326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2774 -27.0522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9854 -27.4611 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9836 -25.8238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6923 -26.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6930 -27.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4015 -27.4551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1098 -27.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1051 -26.2222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3960 -25.8188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9812 -25.0066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2723 -24.6001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2724 -23.7794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5676 -23.3730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8587 -23.7802 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8591 -24.5984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5685 -25.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1513 -23.3711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5729 -27.4579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8657 -27.0466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1597 -27.4512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1549 -28.2687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8621 -28.6800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5742 -28.2738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1519 -22.5539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4433 -23.7791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8191 -27.4501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5286 -27.8509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2401 -28.2529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2477 -29.0700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8103 -25.8093 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5949 -29.5565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8547 -30.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6719 -30.3236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9170 -29.5441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6914 -29.2832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5205 -26.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
4 11 1 0
11 12 1 0
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
15 18 1 0
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
2 19 1 0
18 25 1 0
18 26 1 0
8 27 1 0
27 28 3 0
28 29 1 0
29 30 1 0
9 31 1 0
30 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 30 1 0
35 36 2 0
31 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 503.69Molecular Weight (Monoisotopic): 503.3260AlogP: 4.94#Rotatable Bonds: 6Polar Surface Area: 70.59Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.31CX LogP: 4.52CX LogD: 2.61Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.56Np Likeness Score: -0.90
References 1. Leenders R, Zijlmans R, van Bree B, van de Sande M, Trivarelli F, Damen E, Wegert A, Müller D, Ehlert JE, Feger D, Heidemann-Dinger C, Kubbutat M, Schächtele C, Lenstra DC, Mecinović J, Müller G.. (2019) Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2., 29 (17): [PMID:31350126 ] [10.1016/j.bmcl.2019.06.012 ]